GlassScriptPhysician profile
Jonathan D Bornfreund
NPI 1689634289
$2,146.19
in general payments reported to CMS, 2019-2025
12 companies · $80.00 in 2025
The $80.00 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,190 · 2020: $15.45 · 2021: $384 · 2022: $226 · 2023: $250 · 2025: $80.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $330.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk As | $1,190.44 | 2019 | |
| Medtronic, INC. | $233.72 | 2022-2023 | Intellis Adaptivestim |
| Inari Medical, INC. | $196.36 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Foundation Medicine, INC. | $165.02 | 2021 | |
| Ethicon INC. | $117.89 | 2021 | |
| Boston Scientific Corporation | $85.15 | 2021 | |
| Caris Mpi, INC. | $80.00 | 2025 | Mi Cancer Seek |
| Baxter Healthcare | $46.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.16 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.45 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Bornfreund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.